To this point, the central insulin resistance hypothesis asserts that lack of insulin responsivity in the brain may be implicated in the pathogenesis of various clinical conditions including Parkinson’s disease, schizophrenia, dementia, depression, and type 2 diabetes mellitus (T2DM) [9–13]. This evidence concerns the gene INS and type 2 diabetes mellitus.